Eden Launches Prescription-Only NAD+ Face Cream To Support Skin Resilience And Cellular Wellness

(MENAFN- PR Newswire) The NAD+ Face Cream is dispensed in 15 mL or 30 mL pump bottles and prescribed for topical use, as directed by a licensed provider. It contains 10% nicotinamide adenine dinucleotide (NAD+), a naturally occurring molecule that plays a role in cellular energy processes. This product is prepared by a state-licensed 503A compounding pharmacies.

"People are increasingly seeking skincare options aligned with evolving research in cellular wellness," said Dr. Bronwyn Mahtani, a physician on Eden's Medical Advisory Board. "This formulation represents a personalized approach to skin support, available through a licensed provider consultation."

Eden emphasizes that while NAD+ has been studied in the context of aging and cellular biology, its use in topical applications remains an emerging area of research. Individual results may vary, and no specific cosmetic or therapeutic outcomes are guaranteed. The product should be viewed as part of a broader, science-informed skincare routine.

"Our mission is to expand access to pharmacy-compounded options that patients can explore with medical professionals," said Josh Khan, President and Co-Founder of Eden. "We aim to offer products that reflect evolving research and meet the growing demand for thoughtful, provider-guided wellness solutions."

The NAD+ Face Cream is available exclusively by prescription through Eden's platform. Prescriptions are filled and shipped by state-licensed compounding pharmacies.

About Eden
Eden is a health company that connects individuals with licensed doctors, compounding pharmacies, and nutrition solutions designed to support metabolic health. Through a seamless online experience, Eden helps patients explore personalized treatment options, offering a convenient approach to overall wellness support.

SOURCE Eden

MENAFN28052025003732001241ID1109604937